Implementation of a New UPMC Gamma Knife Radiosurgery Quality Assurance RegistryNiranjan A.a · Layne D.b · Briercheck M.b · Trofimova S.a · Monaco III E.A.a · Kano H.a · Lunsford L.D.a
aDepartment of Neurological Surgery, University of Pittsburgh Medical Center, and bUPMC Technology Development Center, Pittsburgh, PA, USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Object: In this report, we discuss the development of a new, comprehensive, Health Insurance Portability and Accountability Act-compliant electronic quality assurance (QA) registry for Gamma Knife (GK) radiosurgery patients. This registry can be used to query outcomes, link with current hospital electronic medical records, and share data with future corporate or national professional society registries under development. Methods: A clinical task force comprising physicians and regulatory, legal, and information technology (IT) experts was created to define the nomenclature, regulatory requirements, hosting site, and required capabilities of the proposed system. A team of physicians and IT experts defined the clinical parameters and designed the query functions for the registry. Results: The UPMC GK Registry was established as a QA registry exempt from Institutional Review Board oversight. In order to facilitate subsequent query functions (analytics), data entry was created for 3 main categories: brain tumors, vascular malformations, and functional disorders. A Microsoft SQL-based database infrastructure was employed. Conclusions: We developed a new UPMC GK QA registry and successfully migrated our previous data on 13,000 patients into the registry. This simplified and user-friendly registry offers clinicians the opportunity to participate in national registries and to contribute to multicenter evidence-based outcome analyses.
© 2017 S. Karger AG, Basel
- Berkowitz O, Kondziolka D, Bissonette D, Niranjan A, Kano H, Lunsford LD: The evolution of a clinical registry during 25 years of experience with Gamma Knife radiosurgery in Pittsburgh. Neurosurg Focus 2013;34:E4.
- Asher AL, McCormick PC, Selden NR, Ghogawala Z, McGirt MJ: The National Neurosurgery Quality and Outcomes Database and NeuroPoint Alliance: rationale, development, and implementation. Neurosurg Focus 2013;34:E2.
- Asher AL, McGirt MJ, Glassman SD, Groman R, Resnick DK, Mehrlich M, Spivey E, McCormick P: Regulatory considerations for prospective patient care registries: lessons learned from the National Neurosurgery Quality and Outcomes Database. Neurosurg Focus 2013;34:E5.
- Asher AL, Parker SL, Rolston JD, Selden NR, McGirt MJ: Using clinical registries to improve the quality of neurosurgical care. Neurosurg Clin N Am 2015;26:253-263.
- Sheehan JP, Kavanagh BD, Asher A, Harbaugh RE: Inception of a national multidisciplinary registry for stereotactic radiosurgery. J Neurosurg 2016;124:155-162.
- Dreyer NA, Tunis SR, Berger M, Ollendorf D, Mattox P, Gliklich R: Why observational studies should be among the tools used in comparative effectiveness research. Health Aff (Millwood) 2010;29:1818-1825.
- Kondziolka D, Cooper BT, Lunsford LD, Silverman J: Development, implementation, and use of a local and global clinical registry for neurosurgery. Big Data 2015;3:80-89.
- Davis JN, Medbery C 3rd, Sharma S, Danish A, Mahadevan A: The RSSearch Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy. Radiat Oncol 2013;8:275.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.